C6O — Clovis Oncology Balance Sheet
0.000.00%
Last trade - 00:00
- €2.17m
- €538.48m
- $148.76m
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 564 | 520 | 297 | 240 | 143 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8.21 | 15.2 | 34.7 | 30.6 | 33.7 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 627 | 572 | 366 | 311 | 198 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.01 | 26.5 | 43.4 | 42.5 | 25.7 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 735 | 864 | 670 | 606 | 473 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 81.5 | 126 | 133 | 185 | 125 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 368 | 717 | 844 | 764 | 752 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 368 | 146 | -174 | -159 | -279 |
Total Liabilities & Shareholders' Equity | 735 | 864 | 670 | 606 | 473 |
Total Common Shares Outstanding |